ICOS-expressing CD4 T cells induced via TLR4 in the nasal mucosa are capable of inhibiting experimental allergic asthma

Journal of Immunology

Volumn 189, Issue 6, 2012, Pages 2793-2804

  Shalaby, Karim H ^a   Jo, Taisuke ^a   Nakada, Emily ^a   Allard Coutu, Alexandra ^a   Tsuchiya, Kimitake ^a   Hirota, Nobuaki ^a   Qureshi, Salman T ^a   Maghni, Karim ^b   Rioux, Clément R ^c   Martin, James G ^a  

^a MCGILL UNIVERSITY   (Canada)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^c GLAXOSMITHKLINE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIRCH POLLEN ANTIGEN; ICOS PROTEIN; IMMUNOSUPPRESSIVE AGENT; POLLEN ANTIGEN; PROTEIN; PROTOLLIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; EOSINOPHILIA; FEMALE; LUNG LAVAGE; LYMPH NODE; MONOTHERAPY; MOUSE; NONHUMAN; NOSE MUCOSA; PNEUMONIA; PRIORITY JOURNAL; SENSITIZATION;

ANIMALS; ASTHMA; BETULA; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; INDUCIBLE T-CELL CO-STIMULATOR PROTEIN; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NASAL MUCOSA; POLLEN; RESPIRATORY HYPERSENSITIVITY; TOLL-LIKE RECEPTOR 4;

EID: 84866170168     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201194     Document Type: Article

References (66)

1. Holgate, S. T. 2008. Pathogenesis of asthma. Clin. Exp. Allergy 38: 872-897.
2. Lombardi, V., L. Van Overtvelt, S. Horiot, H. Moussu, H. Chabre, A. Louise, A. M. Balazuc, L. Mascarell, and P. Moingeon. 2008. Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigen-specific tolerance via the sublingual route. Clin. Exp. Allergy 38: 1819-1829.
3. Patel, M., D. Xu, P. Kewin, B. Choo-Kang, C. McSharry, N. C. Thomson, and F. Y. Liew. 2005. TLR2 agonist ameliorates established allergic airway inflammation by promoting Th1 response and not via regulatory T cells. J. Immunol. 174: 7558-7563. (Pubitemid 40806259)
4. Bortolatto, J., E. Borducchi, D. Rodriguez, A. C. Keller, E. Faquim-Mauro, K. R. Bortoluci, D. Mucida, E. Gomes, A. Christ, S. Schnyder-Candrian, et al. 2008. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis. Clin. Exp. Allergy 38: 1668-1679.
5. Hollingsworth, J. W., G. S. Whitehead, K. L. Lin, H. Nakano, M. D. Gunn, D. A. Schwartz, and D. N. Cook. 2006. TLR4 signaling attenuates ongoing allergic inflammation. J. Immunol. 176: 5856-5862.
6. Velasco, G., M. Campo, O. J. Manrique, A. Bellou, H. He, R. S. Arestides, B. Schaub, D. L. Perkins, and P. W. Finn. 2005. Toll-like receptor 4 or 2 agonists decrease allergic inflammation. Am. J. Respir. Cell Mol. Biol. 32: 218-224. (Pubitemid 40387648)
7. Moisan, J., P. Camateros, T. Thuraisingam, D. Marion, H. Koohsari, P. Martin, M. L. Boghdady, A. Ding, M. Gaestel, M. C. Guiot, et al. 2006. TLR7 ligand prevents allergen-induced airway hyperresponsiveness and eosinophilia in allergic asthma by a MYD88-dependent and MK2-independent pathway. Am. J. Physiol. Lung Cell. Mol. Physiol. 290: L987-L995. (Pubitemid 43725061)
8. Xirakia, C., O. Koltsida, A. Stavropoulos, A. Thanassopoulou, V. Aidinis, P. Sideras, and E. Andreakos. 2010. Toll-like receptor 7-triggered immune response in the lung mediates acute and long-lasting suppression of experimental asthma. Am. J. Respir. Crit. Care Med. 181: 1207-1216.
9. Jain, V. V., T. R. Businga, K. Kitagaki, C. L. George, P. T. O'Shaughnessy, and J. N. Kline. 2003. Mucosal immunotherapy with CpG oligodeoxynucleotides reverses a murine model of chronic asthma induced by repeated antigen exposure. Am. J. Physiol. Lung Cell. Mol. Physiol. 285: L1137-L1146. (Pubitemid 37310103)
10. Kline, J. N., T. J. Waldschmidt, T. R. Businga, J. E. Lemish, J. V. Weinstock, P. S. Thorne, and A. M. Krieg. 1998. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J. Immunol. 160: 2555-2559. (Pubitemid 28136702)
11. Jones, T., S. Cyr, F. Allard, N. Bellerose, G. H. Lowell, and D. S. Burt. 2004. Protollin: a novel adjuvant for intranasal vaccines. Vaccine 22: 3691-3697. (Pubitemid 39099644)
12. Fries, L. F., A. D. Montemarano, C. P. Mallett, D. N. Taylor, T. L. Hale, and G. H. Lowell. 2001. Safety and immunogenicity of a proteosome-Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults. Infect. Immun. 69: 4545-4553. (Pubitemid 32574456)
13. Treanor, J., C. Nolan, D. O'Brien, D. Burt, G. Lowell, J. Linden, and L. Fries. 2006. Intranasal administration of a proteosome-influenza vaccine is well-tolerated and induces serum and nasal secretion influenza antibodies in healthy human subjects. Vaccine 24: 254-262. (Pubitemid 41790428)
14. Plante, M., T. Jones, F. Allard, K. Torossian, J. Gauthier, N. St-Félix, G. L. White, G. H. Lowell, and D. S. Burt. 2001. Nasal immunization with subunit proteosome influenza vaccines induces serum HAI, mucosal IgA and protection against influenza challenge. Vaccine 20: 218-225. (Pubitemid 32905335)
15. Cyr, S. L., T. Jones, I. Stoica-Popescu, D. Burt, and B. J. Ward. 2007. C57Bl/6 mice are protected from respiratory syncytial virus (RSV) challenge and IL-5 associated pulmonary eosinophilic infiltrates following intranasal immunization with Protollin-eRSV vaccine. Vaccine 25: 3228-3232. (Pubitemid 46505048)
16. Hu, M. C., T. Jones, R. T. Kenney, D. L. Barnard, D. S. Burt, and G. H. Lowell. 2007. Intranasal Protollin-formulated recombinant SARS S-protein elicits respiratory and serum neutralizing antibodies and protection in mice. Vaccine 25: 6334-6340. (Pubitemid 47088756)
17. Jones, T., J. J. Adamovicz, S. L. Cyr, C. R. Bolt, N. Bellerose, L. M. Pitt, G. H. Lowell, and D. S. Burt. 2006. Intranasal Protollin/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection. Vaccine 24: 1625-1632. (Pubitemid 43238239)
18. Chabot, S., A. Brewer, G. Lowell, M. Plante, S. Cyr, D. S. Burt, and B. J. Ward. 2005. A novel intranasal Protollin-based measles vaccine induces mucosal and systemic neutralizing antibody responses and cell-mediated immunity in mice. Vaccine 23: 1374-1383. (Pubitemid 40127330)
19. Frenkel, D., R. Maron, D. S. Burt, and H. L. Weiner. 2005. Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears beta-amyloid in a mouse model of Alzheimer disease. J. Clin. Invest. 115: 2423-2433. (Pubitemid 41266204)
20. Chabot, S. M., T. S. Chernin, M. Shawi, J. Wagner, S. Farrant, D. S. Burt, S. Cyr, and M. R. Neutra. 2007. TLR2 activation by proteosomes promotes uptake of particulate vaccines at mucosal surfaces. Vaccine 25: 5348-5358. (Pubitemid 46992759)
21. Massari, P., P. Henneke, Y. Ho, E. Latz, D. T. Golenbock, and L. M. Wetzler. 2002. Cutting edge: Immune stimulation by neisserial porins is toll-like receptor 2 and MyD88 dependent. J. Immunol. 168: 1533-1537. (Pubitemid 34135744)
22. Duechs, M. J., C. Hahn, E. Benediktus, M. Werner-Klein, A. Braun, H. G. Hoymann, F. Gantner, and K. J. Erb. 2011. TLR agonist mediated suppression of allergic responses is associated with increased innate inflammation in the airways. Pulm. Pharmacol. Ther. 24: 203-214.
23. Bienenstock, J., and M. R. McDermott. 2005. Bronchus- and nasal-associated lymphoid tissues. Immunol. Rev. 206: 22-31. (Pubitemid 41105161)
24. Kim, D. Y., A. Sato, S. Fukuyama, H. Sagara, T. Nagatake, I. G. Kong, K. Goda, T. Nochi, J. Kunisawa, S. Sato, et al. 2011. The airway antigen sampling system: respiratory M cells as an alternative gateway for inhaled antigens. J. Immunol. 186: 4253-4262.
25. McAleer, J. P., and A. T. Vella. 2010. Educating CD4 T cells with vaccine adjuvants: lessons from lipopolysaccharide. Trends Immunol. 31: 429-435.
26. Cucak, H., U. Yrlid, B. Reizis, U. Kalinke, and B. Johansson-Lindbom. 2009. Type I interferon signaling in dendritic cells stimulates the development of lymph-node-resident T follicular helper cells. Immunity 31: 491-501.
27. den Haan, J. M., G. Kraal, and M. J. Bevan. 2007. Cutting edge: Lipopolysaccharide induces IL-10-producing regulatory CD4+ T cells that suppress the CD8 + T cell response. J. Immunol. 178: 5429-5433. (Pubitemid 46674336)
28. Eisenbarth, S. C., D. A. Piggott, J. W. Huleatt, I. Visintin, C. A. Herrick, and K. Bottomly. 2002. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J. Exp. Med. 196: 1645-1651. (Pubitemid 36026476)
29. McAleer, J. P., B. Liu, Z. Li, S. M. Ngoi, J. Dai, M. Oft, and A. T. Vella. 2010. Potent intestinal Th17 priming through peripheral lipopolysaccharide-based immunization. J. Leukoc. Biol. 88: 21-31.
30. Kim, Y. K., S. Y. Oh, S. G. Jeon, H. W. Park, S. Y. Lee, E. Y. Chun, B. Bang, H. S. Lee, M. H. Oh, Y. S. Kim, et al. 2007. Airway exposure levels of lipopolysaccharide determine type 1 versus type 2 experimental asthma. J. Immunol. 178: 5375-5382. (Pubitemid 46595324)
31. Zhu, Z., S. Y. Oh, T. Zheng, and Y. K. Kim. 2010. Immunomodulating effects of endotoxin in mouse models of allergic asthma. Clin. Exp. Allergy 40: 536-546.
32. Gerhold, K., K. Blümchen, A. Bock, C. Seib, P. Stock, T. Kallinich, M. Löhning, U. Wahn, and E. Hamelmann. 2002. Endotoxins prevent murine IgE production, T(H)2 immune responses, and development of airway eosinophilia but not airway hyperreactivity. J. Allergy Clin. Immunol. 110: 110-116. (Pubitemid 36132736)
33. Arora, M., S. L. Poe, T. B. Oriss, N. Krishnamoorthy, M. Yarlagadda, S. E. Wenzel, T. R. Billiar, A. Ray, and P. Ray. 2010. TLR4/MyD88-induced CD11b+Gr-1 int F4/80+ non-migratory myeloid cells suppress Th2 effector function in the lung. Mucosal Immunol. 3: 578-593.
34. Wang, Y., and C. McCusker. 2006. Neonatal exposure with LPS and/or allergen prevents experimental allergic airways disease: development of tolerance using environmental antigens. J. Allergy Clin. Immunol. 118: 143-151. (Pubitemid 43946471)
35. McAdam, A. J., T. T. Chang, A. E. Lumelsky, E. A. Greenfield, V. A. Boussiotis, J. S. Duke-Cohan, T. Chernova, N. Malenkovich, C. Jabs, V. K. Kuchroo, et al. 2000. Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells. J. Immunol. 165: 5035-5040.
36. Coyle, A. J., S. Lehar, C. Lloyd, J. Tian, T. Delaney, S. Manning, T. Nguyen, T. Burwell, H. Schneider, J. A. Gonzalo, et al. 2000. The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. Immunity 13: 95-105.
37. Takahashi, N., K. Matsumoto, H. Saito, T. Nanki, N. Miyasaka, T. Kobata, M. Azuma, S. K. Lee, S. Mizutani, and T. Morio. 2009. Impaired CD4 and CD8 effector function and decreased memory T cell populations in ICOS-deficient patients. J. Immunol. 182: 5515-5527.
38. Smith, K. M., J. M. Brewer, P. Webb, A. J. Coyle, C. Gutierrez-Ramos, and P. Garside. 2003. Inducible costimulatory molecule-B7-related protein 1 interactions are important for the clonal expansion and B cell helper functions of naive, Th1, and Th2 T cells. J. Immunol. 170: 2310-2315. (Pubitemid 36245616)
39. Moore, T. V., B. S. Clay, J. L. Cannon, A. Histed, R. A. Shilling, and A. I. Sperling. 2011. Inducible costimulator controls migration of T cells to the lungs via down-regulation of CCR7 and CD62L. Am. J. Respir. Cell Mol. Biol. 45: 843-850.
40. Burmeister, Y., T. Lischke, A. C. Dahler, H. W. Mages, K. P. Lam, A. J. Coyle, R. A. Kroczek, and A. Hutloff. 2008. ICOS controls the pool size of effectormemory and regulatory T cells. J. Immunol. 180: 774-782.
41. Chen, Y., S. Shen, B. K. Gorentla, J. Gao, and X. P. Zhong. 2012. Murine regulatory T cells contain hyperproliferative and death-prone subsets with differential ICOS expression. J. Immunol. 188: 1698-1707.
42. McCusker, C., M. Chicoine, Q. Hamid, and B. Mazer. 2002. Site-specific sensitization in a murine model of allergic rhinitis: role of the upper airway in lower airways disease. J. Allergy Clin. Immunol. 110: 891-898. (Pubitemid 36005877)
43. Gereda, J. E., D. Y. Leung, A. Thatayatikom, J. E. Streib, M. R. Price, M. D. Klinnert, and A. H. Liu. 2000. Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma. Lancet 355: 1680-1683. (Pubitemid 30248480)
44. Schaub, B., J. Liu, S. Höppler, I. Schleich, J. Huehn, S. Olek, G. Wieczorek, S. Illi, and E. von Mutius. 2009. Maternal farm exposure modulates neonatal immune mechanisms through regulatory T cells. J. Allergy Clin. Immunol. 123: 774-782, e5.
45. Braun-Fahrländer, C., J. Riedler, U. Herz, W. Eder, M. Waser, L. Grize, S. Maisch, D. Carr, F. Gerlach, A. Bufe, et al Allergy and Endotoxin Study Team. 2002. Environmental exposure to endotoxin and its relation to asthma in school-age children. N. Engl. J. Med. 347: 869-877.
46. Eder, W., W. Klimecki, L. Yu, E. von Mutius, J. Riedler, C. Braun-Fahrländer, D. Nowak, and F. D. Martinez; Allergy And Endotoxin Alex Study Team. 2005. Opposite effects of CD 14/-260 on serum IgE levels in children raised in different environments. J. Allergy Clin. Immunol. 116: 601-607. (Pubitemid 41267134)
47. Fagerås Böttcher, M., M. Hmani-Aifa, A. Lindström, M. C. Jenmalm, X. M. Mai, L. Nilsson, H. A. Zdolsek, B. Björkstén, P. Söderkvist, and O. Vaarala. 2004. ATLR4 polymorphism is associated with asthma and reduced lipopolysaccharide-induced interleukin-12(p70) responses in Swedish children. J. Allergy Clin. Immunol. 114: 561-567. (Pubitemid 39194929)
48. Tanamoto, K., U. Zähringer, G. R. McKenzie, C. Galanos, E. T. Rietschel, O. Lüderitz, S. Kusumoto, and T. Shiba. 1984. Biological activities of synthetic lipid A analogs: pyrogenicity, lethal toxicity, anticomplement activity, and induction of gelation of Limulus amoebocyte lysate. Infect. Immun. 44: 421-426. (Pubitemid 14139008)
49. Rietschel, E. T., H. Brade, L. Brade, K. Brandenburg, U. Schade, U. Seydel, U. Zähringer, C. Galanos, O. Lüderitz, O. Westphal, et al. 1987. Lipid A, the endotoxic center of bacterial lipopolysaccharides: relation of chemical structure to biological activity. Prog. Clin. Biol. Res. 231: 25-53.
50. Brandtzaeg, P. 2011. Potential of nasopharynx-associated lymphoid tissue for vaccine responses in the airways. Am. J. Respir. Crit. Care Med. 183: 1595- 1604.
51. Unger, W. W., F. Hauet-Broere, W. Jansen, L. A. van Berkel, G. Kraal, and J. N. Samsom. 2003. Early events in peripheral regulatory T cell induction via the nasal mucosa. J. Immunol. 171: 4592-4603. (Pubitemid 37310575)
52. Wolvers, D. A., C. J. Coenen-de Roo, R. E. Mebius, M. J. van der Cammen, F. Tirion, A. M. Miltenburg, and G. Kraal. 1999. Intranasally induced immunological tolerance is determined by characteristics of the draining lymph nodes: studies with OVA and human cartilage gp-39. J. Immunol. 162: 1994-1998. (Pubitemid 29288817)
53. Cyr, S. L., I. Angers, L. Guillot, I. Stoica-Popescu, M. Lussier, S. Qureshi, D. S. Burt, and B. J. Ward. 2009. TLR4 and MyD88 control protection and pulmonary granulocytic recruitment in a murine intranasal RSV immunization and challenge model. Vaccine 27: 421-430.
54. Fransen, F., R. M. Stenger, M. C. Poelen, H. H. van Dijken, B. Kuipers, C. J. Boog, J. P. van Putten, C. A. van Els, and P. van der Ley. 2010. Differential effect of TLR2 and TLR4 on the immune response after immunization with a vaccine against Neisseria meningitidis or Bordetella pertussis. PLoS ONE 5: e15692.
55. Gerhold, K., K. Bluemchen, A. Franke, P. Stock, and E. Hamelmann. 2003. Exposure to endotoxin and allergen in early life and its effect on allergen sensitization in mice. J. Allergy Clin. Immunol. 112: 389-396. (Pubitemid 36981381)
56. Gerhold, K., A. Avagyan, C. Seib, R. Frei, J. Steinle, B. Ahrens, A. M. Dittrich, K. Blumchen, R. Lauener, and E. Hamelmann. 2006. Prenatal initiation of endotoxin airway exposure prevents subsequent allergen-induced sensitization and airway inflammation in mice. J. Allergy Clin. Immunol. 118: 666-673. (Pubitemid 44301398)
57. Gerhold, K., A. Avagyan, E. Reichert, K. Blumchen, U. Wahn, and E. Hamelmann. 2008. Lipopolysaccharides modulate allergen-specific immune regulation in a murine model of mucosal tolerance induction. Int. Arch. Allergy Immunol. 147: 25-34.
58. Ito, T., S. Hanabuchi, Y. H. Wang, W. R. Park, K. Arima, L. Bover, F. X. Qin, M. Gilliet, and Y. J. Liu. 2008. Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. Immunity 28: 870-880.
59. Pot, C., H. Jin, A. Awasthi, S. M. Liu, C. Y. Lai, R. Madan, A. H. Sharpe, C. L. Karp, S. C. Miaw, I. C. Ho, and V. K. Kuchroo. 2009. Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J. Immunol. 183: 797-801.
60. Watanabe, M., Y. Takagi, M. Kotani, Y. Hara, A. Inamine, K. Hayashi, S. Ogawa, K. Takeda, K. Tanabe, and R. Abe. 2008. Down-regulation of ICOS ligand by interaction with ICOS functions as a regulatory mechanism for immune responses. J. Immunol. 180: 5222-5234.
61. Tuettenberg, A., E. Huter, M. Hubo, J. Horn, J. Knop, B. Grimbacher, R. A. Kroczek, S. Stoll, and H. Jonuleit. 2009. The role of ICOS in directing T cell responses: ICOS-dependent induction of T cell anergy by tolerogenic dendritic cells. J. Immunol. 182: 3349-3356.
62. Vermeiren, J., J. L. Ceuppens, M. Van Ghelue, P. Witters, D. Bullens, H. W. Mages, R. A. Kroczek, and S.W. Van Gool. 2004. Human T cell activation by costimulatory signal-deficient allogeneic cells induces inducible costimulator-expressing anergic T cells with regulatory cell activity. J. Immunol. 172: 5371-5378. (Pubitemid 38542036)
63. Akbari, O., G. J. Freeman, E. H. Meyer, E. A. Greenfield, T. T. Chang, A. H. Sharpe, G. Berry, R. H. DeKruyff, and D. T. Umetsu. 2002. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med. 8: 1024-1032. (Pubitemid 35033708)
64. Whitehead, G. S., R. H. Wilson, K. Nakano, L. H. Burch, H. Nakano, and D. N. Cook. 2012. IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease. J. Allergy Clin. Immunol. 129: 207-215, e1-e5.
65. Nie, X., G. Cai, W. Zhang, H. Wang, B. Wu, Q. Li, and Q. Shen. 2012. Lipopolysaccharide mediated mast cells induce IL-10 producing regulatory T cells through the ICOSL/ICOS axis. Clin. Immunol. 142: 269-279.
66. Zhou, Z., K. Hoebe, X. Du, Z. Jiang, L. Shamel, and B. Beutler. 2005. Antagonism between MyD88- and TRIF-dependent signals in B7RP-1 up-regulation. Eur. J. Immunol. 35: 1918-1927. (Pubitemid 40862340)